Search hospitals > Massachusetts > Boston
Boston Medical Center
Claim this profileBoston, Massachusetts 02118
Global Leader in Cancer
Global Leader in Human Immunodeficiency Virus Infection
Conducts research for Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
827 reported clinical trials
82 medical researchers
Summary
Boston Medical Center is a medical facility located in Boston, Massachusetts. This center is recognized for care of Cancer, Human Immunodeficiency Virus Infection, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer and other specialties. Boston Medical Center is involved with conducting 827 clinical trials across 966 conditions. There are 82 research doctors associated with this hospital, such as Umit Tapan, MD, M B, Hussein Assi, and Kimberley S. Mak.Area of expertise
1Cancer
Global LeaderStage IV
Stage II
Stage III
2Human Immunodeficiency Virus Infection
Global LeaderTop PIs
Umit Tapan, MDBoston Medical Center4 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
9 reported clinical trials
21 drugs studied
M BColumbia University Medical Center2 years of reported clinical research
Studies Postoperative Pain
Studies Polycystic Ovary Syndrome
8 reported clinical trials
14 drugs studied
Hussein AssiBoston Medical Center5 years of reported clinical research
Studies Pancreatic Neuroendocrine Tumors
Studies Tumors
6 reported clinical trials
14 drugs studied
Kimberley S. MakBoston Medical Center3 years of reported clinical research
Studies Lung Cancer
Studies Cancer
5 reported clinical trials
16 drugs studied
Clinical Trials running at Boston Medical Center
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Small Cell Lung Cancer
Multiple Myeloma
Cancer
Amyloidosis
Plasma Cell Neoplasms
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Sacituzumab Govitecan + Talazoparib
for Breast Cancer
This research is studying the effect of Antibody-Drug Conjugate Sacituzumab Govitecan in Combination with the Poly (Adenosine Diphosphate \[ADP\]-Ribose) Polymerase (PARP) Inhibitor Talazoparib in Patients with Metastatic Triple-Negative Breast Cancer.
Recruiting3 awards Phase 1 & 211 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Boston Medical Center?
Boston Medical Center is a medical facility located in Boston, Massachusetts. This center is recognized for care of Cancer, Human Immunodeficiency Virus Infection, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer and other specialties. Boston Medical Center is involved with conducting 827 clinical trials across 966 conditions. There are 82 research doctors associated with this hospital, such as Umit Tapan, MD, M B, Hussein Assi, and Kimberley S. Mak.
Where is Boston Medical Center located?
To reach Boston Medical Center in Boston, Massachusetts:
1. Take I-93 South.
2. Exit at Exit 18 (Mass Ave).
3. Turn right onto the access road, then right again onto Massachusetts Ave.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Boston Medical Center:
- Contact the Financial Counseling Department at (617) 414-5155. Visit the Shapiro Center (725 Albany Street, Suite 3C, Boston, MA 02118) or Yawkey Center (850 Harrison Avenue, Ground Floor, Boston, MA 02118).
- Apply for the Charity Care Program for discounts on elective services for uninsured or underinsured patients demonstrating financial need.
- For insurance matters, contact Billing at (617) 638-6157 or Patient Financial Services at (617) 414-5155.
What insurance does Boston Medical Center accept?
Boston Medical Center (BMC) accepts a wide range of insurance plans, including Aetna, AllWays Health Partners, Blue Cross Blue Shield, BMC WellSense Plan, Cigna, Commonwealth Care Alliance, Fallon, Harvard Pilgrim Health Plan, Humana Military, Kaiser, MassHealth, MultiPlan, Senior Whole Health, Tufts Health Plan, and United Healthcare, covering both PPO and HMO plans. Patients are advised to bring their insurance card to all appointments. For those without insurance, BMC offers assistance through Patient Financial Services to explore coverage options, and special payment plans can be arranged. Patients involved in motor vehicle accidents or workers' compensation cases must provide specific insurance and case details. BMC also provides various medical plan options with differing benefits and provider networks.
What awards or recognition has Boston Medical Center received?
Boston Medical Center (BMC) is an ACS NSQIP® Meritorious hospital, acknowledged for its excellence in surgical care. It has been named one of America's 250 Best Hospitals by Healthgrades and a Great Workplace for Diversity by Newsweek. BMC also received the Gastrointestinal Care Excellence Award from Healthgrades, highlighting its clinical expertise, equity, and diversity initiatives.